2 nominees · 6 ballot items.
The Greenland Technologies Holding Corporation 2025 proxy includes six proposals for shareholders: adoption of new Memorandum of Association and Articles of Association (New M&A Adoption Proposal); implementation of a dual-class share structure (Share Capital Reorganization Proposal); re-classification of Trendway Capital Limited’s Ordinary Shares into Class B and the remainder into Class A (Share Re-classification Proposal); election of two Class II directors (Director Nominees) to hold office; ratification of Enrome LLP as the independent registered public accounting firm for 2025 (Auditor Ratification Proposal); and an adjournment proposal to allow continuation of proxy solicitation if needed (Adjournment Proposal). The Board unanimously recommends voting FOR all six proposals.
Approve, as a Resolution of Members, the adoption of new Memorandum of Association and new Articles of Association in the form presented to the meeting and annexed as Annex A; and to be effective upon filing in the British Virgin Islands, with implementation conditional upon approval of Proposal 2.
Approve the implementation of a dual-class structure: ordinary shares will be re-designated into Class A Ordinary Shares (1 vote per share) and Class B Ordinary Shares (25 votes per share) as described in the Memorandum, conditional on the New M&A Adoption Proposal and related approvals.
Approve the re-classification of issued Ordinary Shares held by Trendway Capital Limited as Class B Ordinary Shares and the remaining Ordinary Shares as Class A Ordinary Shares, conditional on approvals of Proposals 1 and 2.
Approve the appointment of Peter Zuguang Wang and Bo (Frank) Shen as Class II directors, to hold office until the Company’s second AGM following their election, in accordance with the Articles.
Ratify Enrome LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025 (and related auditor responsibilities).
Approve, as a Resolution of Members, for the chairperson to adjourn the Meeting to a later date, if necessary for soliciting additional proxies or to allow for continued voting as needed.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | ACADIAN ASSET MANAGEMENT LLC | 0.9% | 175,660 | $123K |
| 2 | Mariner, LLC | 0.2% | 40,596 | $28K |
| 3 | BNP PARIBAS FINANCIAL MARKETS | 0.1% | 30,502 | $21K |
| 4 | JANE STREET GROUP, LLC | 0.1% | 30,477 | $21K |
| 5 | GSA CAPITAL PARTNERS LLP | 0.1% | 24,789 | $17K |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 0.1% | 13,703 | $10K |
| 7 | UBS Group AG | 0.1% | 12,570 | $9K |
| 8 | XTX Topco Ltd | 0.1% | 11,511 | $8K |
| 9 | HRT FINANCIAL LP | 0.1% | 11,304 | $8K |
| 10 | Sanctuary Advisors, LLC | 0.1% | 10,700 | $7K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.